These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 760691)

  • 1. Saralasin testing for renin-dependent hypertension.
    Weber MA
    Arch Intern Med; 1979 Jan; 139(1):93-5. PubMed ID: 760691
    [No Abstract]   [Full Text] [Related]  

  • 2. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 3. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK; Williams GH
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of saralasin to evaluate the function of the brain renin-angiotensin system.
    Reid IA
    Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of saralasin in the recognition of angiotensinogenic hypertension.
    Streeten DH; Dalakos TG; Anderson GH
    Prog Biochem Pharmacol; 1976; 12():214-26. PubMed ID: 1019165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of a competitive antagonist of angiotensin II (saralasin) in the diagnosis and therapy of arterial hypertension].
    Mazza F; Messore T; Catzola A; Corvino A; Genovese A; Catalano M; Mercone G
    Recenti Prog Med; 1983 Apr; 74(4):415-29. PubMed ID: 6348901
    [No Abstract]   [Full Text] [Related]  

  • 8. A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).
    Keim HJ; Drayer JI; Case DB; Lopez-Ovejero J; Wallace JM; Weber MA; Laragh JH
    N Engl J Med; 1976 Nov; 295(21):1175-7. PubMed ID: 980020
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C
    Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
    [No Abstract]   [Full Text] [Related]  

  • 12. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients.
    Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Nielsen MD; Christensen NJ; Giese J
    Acta Med Scand; 1979; 205(7):547-55. PubMed ID: 474180
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of saralasin in end-stage renal disease.
    Fadem SZ; Lifschitz MD
    Kidney Int Suppl; 1979 Mar; (9):S93-100. PubMed ID: 289869
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin blockade in coarctation of the aorta.
    Ribeiro AB; Krakoff LR
    N Engl J Med; 1976 Jul; 295(3):148-50. PubMed ID: 1272332
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
    Giuliani L; Martorana G; Giberti C
    Minerva Nefrol; 1979; 26(4):623-8. PubMed ID: 396491
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB; Wallace JM; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
    [No Abstract]   [Full Text] [Related]  

  • 19. Reciprocal relation between renin dependency and sodium dependency in essential hypertension.
    Gavras H; Ribeiro AB; Gavras I; Brunner HR
    N Engl J Med; 1976 Dec; 295(23):1278-83. PubMed ID: 980059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of saralasin in hypertensive uremic patients under periodic hemodialysis treatment].
    Cappelli G; Vagge R; Lamperi S
    Minerva Nefrol; 1979; 26(1):5-8. PubMed ID: 471322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.